Placental-origin Disease Diagnosis and Treatment Advances
Abstract
clinical advancements, emphasizing molecular insights and innovative diagnostics and treatments. It notes that placental issues are associated
with signaling pathway dysregulation and epigenetic responses to environmental influences. Clinical tools like Doppler ultrasound and noninvasive DNA testing improve early disease detection. Personalized medicine, considering genetic and lifestyle elements, presents new management strategies. Challenges due to disease diversity and individual differences remain, with a call for future research to focus on biomarker
identification, environmental-genetic interactions, and interdisciplinary efforts to advance diagnostics and therapeutics.
Keywords
Full Text:
PDFReferences
[1] Miao T, Xiao Z, Weidong F, et al. Advance in placenta drug delivery: concern for placenta-originated disease therapy. Drug delivery,
2023, 30(1): 2184315-2184315.
[2] A T, L B, A Z B, et al. Sex differences in placenta-derived markers and later autistic traits in children. Translational psychiatry, 2023,
13(1): 256-256.
[3] Gu Mengqi. The impact of umbilical cord placental exosomes in preeclampsia on fetal kidney growth and development [D]. Shandong
University, 2023. DOI:10.27272/d.cnki.gshdu.2023.002774.
[4] Liu Shiyang. Research on the differential gene expression profile in placental tissue of preeclampsia [D]. Kunming Medical University,
2023. DOI:10.27202/d.cnki.gkmyc.2023.000845.
[5] Zheng Xiaofang. Clinical data and placental pathological changes in preeclampsia combined with fetal growth restriction [D].
Guangzhou Medical University, 2023. DOI:10.27043/d.cnki.ggzyc.2023.000165.
[6] Li Lanhua, Yang Shanshan, Yu Chunxiang. Expression changes and significance of hypoxia-inducible factor-1?, endoplasmic reticulum
aminopeptidase 1, and brain-derived neurotrophic factor in placenta of preeclampsia [J]. Journal of Traditional Chinese Medicine and
Western Medicine, 2022, 20(22): 4191-4194.
[7] Elham R, Maryam M, Mahmoud G D, et al. Potential and challenges of placenta-derived decidua stromal cell therapy in inflammationassociated disorders. Human immunology, 2022, 83(7): 580-588.
[8] Amirhesam B, Kasra M, Farnaz N, et al. Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-
associated acute respiratory distress syndrome (ARDS) and systemic inflammation. Stem cell research & therapy, 2022, 13(1): 126-126.
[9] Feng Xiaoling, Jiang Tianyue, Zhang Yang. Placental autophagy and preeclampsia [J]. Chinese Journal of Family Planning, 2022,
30(01): 236-240.
[10] Sun Li, Wu Qi Chang, Xu Yameng, et al. Analysis of placental-related factors in early-onset fetal growth restriction [J]. Chinese Maternal and Infant Health Care, 2021, 36(24): 5782-5785. DOI:10.19829/j.zgfybj.issn.1001-4411.2021.24.053.
[11] Dong W Y, Jin Y K, Jeong M C, et al. MIT-001 Restores Human Placenta-Derived Mesenchymal Stem Cells by Enhancing Mitochondrial Quiescence and Cytoskeletal Organization [J]. International Journal of Molecular Sciences, 2021, 22(10): 5062-5062.
[12] Jin Huili. The effect of MitoQ, an antioxidant given in early pregnancy, on placental angiogenesis in mice [D]. Chongqing Medical University, 2021. DOI:10.27674/d.cnki.gcyku.2021.000740.
[13] Peng X, Yeling M, Hongyu W, et al. Placenta-Derived MicroRNAs in the Pathophysiology of Human Pregnancy [J]. Frontiers in Cell
and Developmental Biology, 2021, 9
[14] afa? S, Micha? J, Zuzanna D, et al. Human placenta-derived stem cells - recent findings based on the molecular science [J]. Medical
Journal of Cell Biology, 2020, 8(4): 164-169.
[15] Kathy K, Shuyang H, Mary N, et al. Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell
Malignancies[J]. Blood, 2019, 134(Supplement_1): 3222-3222.
[16] Wen Hong. Research on the role and mechanism of placental-origin miRNA in selective growth restriction [D]. Zhejiang University,
2019. DOI:10.27461/d.cnki.gzjdx.2019.002495.
[17] Zhang Meiyan. Research on the expression of BDNF in placenta of preeclamptic mothers and the polymorphism of mother and fetus
Val66Met and its impact on neonatal outcomes [D]. Qingdao University, 2019. DOI:10.27262/d.cnki.gqdau.2019.001680.
[18] Gu Hangchao. Research on the induction of hypertension by galectin-14 in placental-origin extracellular vesicles and its mechanism [D].
Shanghai Jiao Tong University, 2019. DOI:10.27307/d.cnki.gsjtu.2019.004351.
[19] Chengguang W, Long C, Zhou Y H, et al. Comparison of the Proliferation and Differentiation Potential of Human Urine-, Placenta Decidua Basalis-, and Bone Marrow-Derived Stem Cells [J]. Stem Cells International, 2018
[20] Kim W H, Lee H, Kang M J, et al. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection.
DOI: http://dx.doi.org/10.70711/mhr.v2i3.4917
Refbacks
- There are currently no refbacks.
